30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Performance

Overall performance
2.2

Performance over holding periods
2.2
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 97% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Catalyst Pharmaceuticals Inc Feb. 19, 2015 -
Executive Chairman of the Board Broadridge Financial Solutions Inc Jan. 2, 2019 -
Independent Director Opiant Pharmaceuticals Inc June 12, 2018 -
Chief Executive Officer, Director Broadridge Financial Solutions Inc Sept. 1, 2017 - Jan. 2, 2019
Chairman of the Board, President, Chief Executive Officer, Interim Principal Financial and Accounting Officer Palisade Bio Inc April 30, 2017 - Aug. 6, 2018
Independent Director Synergy Pharmaceuticals LLC June 30, 2015 - June 12, 2018
President, Chief Executive Officer, Director Broadridge Financial Solutions Inc Jan. 1, 2014 - Sept. 1, 2017
Chairman of the Board, President, Chief Executive Officer Palisade Bio Inc June 13, 2016 - April 30, 2017
Independent Director ADT Security Corp Jan. 9, 2014 - Jan. 1, 2017
President, Chief Executive Officer, Director Palisade Bio Inc Feb. 15, 2016 - June 13, 2016
Chief Executive Officer, Director Broadridge Financial Solutions Inc Jan. 1, 2007 - Jan. 1, 2014

Rich Daly's trades of Catalyst Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-08-28 2025-08-26 S Sale
94,165 -12.9%
454.73
US$199,105
94,165 -12.9% 454.73 US$199,105
2025-08-26 2025-08-26 PrS Proposed sale
46,130
24.63
US$2,716,062
46,130 24.63 US$2,716,062
2025-05-30 2025-05-30 PrS Proposed sale
67,008
487.90
US$1,198,272
67,008 487.90 US$1,198,272
2024-06-05 2024-06-04 S Sale
17,323 -6.9%
15.98
US$276,735
17,323 -6.9% 15.98 US$276,735
2024-06-04 2024-06-04 PrS Proposed sale
17,323
15.98
US$276,735
17,323 15.98 US$276,735
2020-03-02 2019-09-12 B Purchase
1,800 +inf%
13.90
US$25,020
1,800 +inf% 13.90 US$25,020
2016-09-21 2016-09-19 PlS Planned sale
51,353 -16.6%
68.69
US$3,527,361
51,353 -16.6% 68.69 US$3,527,361